{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:51:16Z","timestamp":1782481876777,"version":"3.54.5"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular Kidney Metabolic (CKM) syndrome is a complex systemic condition, but identifying patients at advanced stages (Stages 3 or 4) remains a clinical challenge due to the lack of readily available markers. The C-reactive Protein-Albumin-Lymphocyte (CALLY) index is a composite measure reflecting the axis of inflammation, nutrition, and immunity. However, its role across integrated advanced CKM risk stratification and all-cause mortality assessment, particularly with cross-population validation, remains insufficiently clarified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study used a dual-cohort design. We analyzed a nationally representative population from the United States (NHANES,\n                      <jats:italic>N<\/jats:italic>\n                      = 11,690) and an independent clinical cohort from a Chinese hospital (\n                      <jats:italic>N<\/jats:italic>\n                      = 1,056) for external validation. The associations between the CALLY index and advanced CKM or all-cause mortality were assessed using survey-weighted logistic regression and Cox proportional hazards models. Non-linear dose-response relationships were evaluated using restricted cubic splines (RCS). We further measured the incremental value of the CALLY index over standard models through the Net Reclassification Improvement (NRI), Integrated Discrimination Improvement (IDI), and Decision Curve Analysis (DCA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the NHANES cohort, a higher CALLY index was associated with a lower risk of advanced CKM (Q4 vs. Q1: OR 0.70, 95% CI 0.54\u20130.90) and all-cause mortality (Q4 vs. Q1: HR 0.64, 95% CI 0.55\u20130.76). In the external validation cohort, participants in the highest CALLY quartile had lower odds of advanced CKM (Q4 vs. Q1: OR 0.41, 95% CI 0.28\u20130.62). Both cohorts showed a clear L-shaped non-linear association. Adding the CALLY index to conventional models significantly improved risk reclassification (NRI 0.1968 in NHANES and 0.4134 in the validation cohort, both\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). DCA also indicated that the CALLY-integrated model provided greater model-based net benefit across a range of threshold probabilities, despite relatively small changes in the area under the curve (AUC).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The CALLY index is a simple, routinely available composite indicator that may support advanced CKM risk stratification and mortality risk assessment. It provided incremental risk-stratification information in this study and may help identify individuals at higher risk across the CKM spectrum.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1811091","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:27:16Z","timestamp":1782480436000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The CALLY index for risk stratification of advanced cardiovascular-kidney-metabolic syndrome and mortality: a dual-cohort study from NHANES and a real-world clinical setting"],"prefix":"10.3389","volume":"13","author":[{"given":"Peiting","family":"Chen","sequence":"first","affiliation":[{"name":"Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]},{"name":"Department of Laboratory Medicine, Wuming Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjia","family":"Deng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Tan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Tang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruier","family":"Huang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease.","volume":"46","author":"Marx-Sch\u00fctt","year":"2025","journal-title":"Eur Heart J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-physiol-060821-014008","article-title":"Alcohol-associated tissue injury: Current views on pathophysiological mechanisms.","volume":"84","author":"Simon","year":"2022","journal-title":"Annu Rev Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s12276-023-00982-6","article-title":"Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation.","volume":"55","author":"Lee","year":"2023","journal-title":"Exp Mol Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association.","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association.","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation."},{"key":"B7","doi-asserted-by":"publisher","first-page":"744129","DOI":"10.3389\/fimmu.2021.744129","article-title":"C-reactive protein and cancer: Interpreting the differential bioactivities of its pentameric and monomeric, modified isoforms.","volume":"12","author":"Potempa","year":"2021","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1264383","DOI":"10.3389\/fimmu.2023.1264383","article-title":"A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects.","volume":"14","author":"Olson","year":"2023","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"102627","DOI":"10.1016\/j.eclinm.2024.102627","article-title":"The association between hypoalbuminemia and risk of death due to cancer and vascular disease in individuals aged 65 years and older: findings from the prospective moli-sani cohort study.","volume":"72","author":"Di Castelnuovo","year":"2024","journal-title":"EClinicalMedicine."},{"key":"B10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/ajcn\/nqaa311","article-title":"The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure.","volume":"113","author":"Sze","year":"2021","journal-title":"Am J Clin Nutr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e185218","DOI":"10.1172\/JCI185218","article-title":"T cells in cardiac health and disease.","volume":"135","author":"Mart\u00edn","year":"2025","journal-title":"J Clin Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.hpb.2021.06.414","article-title":"Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.","volume":"24","author":"Iida","year":"2022","journal-title":"HPB (Oxford)."},{"key":"B13","doi-asserted-by":"publisher","first-page":"112212","DOI":"10.1016\/j.diabres.2025.112212","article-title":"Association between hemoglobin, albumin, lymphocyte, and platelet score and all-cause and cardiovascular mortality among population with diabetes: evidence from the NHANES 2003\u20132016.","volume":"224","author":"He","year":"2025","journal-title":"Diab Res Clin Pract."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1605067","DOI":"10.3389\/fimmu.2025.1605067","article-title":"Pretreatment CALLY index as promising novel biomarker in the prediction of surgical and oncological outcomes in esophageal cancer: a multi-center retrospective cohort study.","volume":"16","author":"Meng","year":"2025","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1131496","DOI":"10.3389\/fimmu.2023.1131496","article-title":"Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: from the investigation on nutrition status and clinical outcome of common cancers study.","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.clnu.2024.12.032","article-title":"Association between C-reactive protein-albumin-lymphocyte index and overall survival in patients with esophageal cancer.","volume":"45","author":"Jia","year":"2025","journal-title":"Clin Nutr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"112191","DOI":"10.1016\/j.nut.2023.112191","article-title":"Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.","volume":"116","author":"Zhang","year":"2023","journal-title":"Nutrition."},{"key":"B18","doi-asserted-by":"publisher","first-page":"13672","DOI":"10.1038\/s41598-025-97538-7","article-title":"The value of the CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in acute ischemic stroke.","volume":"15","author":"Pan","year":"2025","journal-title":"Sci Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/17520363.2025.2483159","article-title":"A novel indicator of all-cause mortality in acute coronary syndrome: the CALLY index.","volume":"19","author":"G\u00fcven","year":"2025","journal-title":"Biomark Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e47718","DOI":"10.1097\/MD.0000000000047718","article-title":"Age-related associations between the CALLY index and advanced cardiovascular-kidney-metabolic (CKM) syndrome: insights from NHANES population data.","volume":"105","author":"Liu","year":"2026","journal-title":"Medicine (Baltimore)."},{"key":"B21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13098-025-02068-x","article-title":"Prognostic significance of the CALLY index for mortality among patients with cardiovascular-kidney-metabolic syndrome stages 0\u20133.","volume":"18","author":"Lin","year":"2026","journal-title":"Diabetol Metab Syndr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association.","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation."},{"key":"B23","doi-asserted-by":"publisher","first-page":"112860","DOI":"10.1016\/j.intimp.2024.112860","article-title":"Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.","volume":"141","author":"Ji","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"24380","DOI":"10.1038\/s41598-025-09898-9","article-title":"The relationship between C-reactive protein-albumin-lymphocyte index and peripheral artery disease.","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.clnesp.2024.06.054","article-title":"C-reactive protein-albumin-lymphocyte index as a feasible nutrition-immunity-inflammation marker of the outcome of all-cause and cardiovascular mortality in elderly.","volume":"63","author":"Luo","year":"2024","journal-title":"Clin Nutr ESPEN."},{"key":"B26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-025-02742-4","article-title":"Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome.","volume":"24","author":"Zheng","year":"2025","journal-title":"Cardiovasc Diabetol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1186\/s40001-025-02929-1","article-title":"Impact of systemic immune inflammation index and systemic inflammation response index on all-cause and cardiovascular mortality in cardiovascular-kidney-metabolic syndrome.","volume":"30","author":"Huang","year":"2025","journal-title":"Eur J Med Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.2337\/dc21-0811","article-title":"Natriuretic peptides and risk of type 2 diabetes: results from the biomarkers for cardiovascular risk assessment in Europe (BiomarCaRE) consortium.","volume":"44","author":"Sujana","year":"2021","journal-title":"Diabetes Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12933-025-02876-5","article-title":"Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals.","volume":"24","author":"Chen","year":"2025","journal-title":"Cardiovasc Diabetol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"120521","DOI":"10.1016\/j.atherosclerosis.2025.120521","article-title":"Association between cardiovascular-kidney-metabolic syndrome, inflammatory biomarkers, and cardiovascular outcomes: Insights from the MESA study.","volume":"410","author":"Ahmad","year":"2025","journal-title":"Atherosclerosis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/antiox12010193","article-title":"Development of dietary thiol antioxidant via reductive modification of whey protein and its application in the treatment of ischemic kidney injury.","volume":"12","author":"Sui","year":"2023","journal-title":"Antioxidants (Basel)."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1595119","DOI":"10.3389\/fnut.2025.1595119","article-title":"Altered albumin\/neutrophil to lymphocyte ratio are associated with all-cause and cardiovascular mortality for advanced cardiovascular-kidney-metabolic syndrome.","volume":"12","author":"Yin","year":"2025","journal-title":"Front Nutr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1038\/s41467-023-38238-6","article-title":"Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection.","volume":"14","author":"Ahuja","year":"2023","journal-title":"Nat Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: signaling pathways and intervention therapies.","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9494","DOI":"10.1021\/acs.nanolett.4c01869","article-title":"Antioxidant and immunomodulatory polymer vesicles for effective diabetic wound treatment through ROS scavenging and immune modulating.","volume":"24","author":"Zhang","year":"2024","journal-title":"Nano Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1053\/j.ajkd.2025.04.011","article-title":"Systemic inflammation and the risks of adverse kidney outcomes in adults with atherosclerotic cardiovascular disease.","volume":"86","author":"Mazhar","year":"2025","journal-title":"Am J Kidney Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/bmjebm-2020-111603","article-title":"Bayesian interpretation of p values in clinical trials.","volume":"27","author":"Ferguson","year":"2022","journal-title":"BMJ Evid Based Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jchf.2022.02.007","article-title":"Covariate adjustment in cardiovascular randomized controlled trials: its value, current practice, and need for improvement.","volume":"10","author":"Pirondini","year":"2022","journal-title":"JACC Heart Fail."},{"key":"B41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12933-025-02940-0","article-title":"Association of estimated glucose disposition rate with aging acceleration and mortality risk in individuals with cardiovascular-kidney-metabolic syndrome: evidence from two large national population-based studies.","volume":"24","author":"Tan","year":"2025","journal-title":"Cardiovasc Diabetol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models.","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making."},{"key":"B44","doi-asserted-by":"publisher","first-page":"20090","DOI":"10.1038\/s41598-025-03985-7","article-title":"The CRP-albumin-lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system.","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"370","DOI":"10.21873\/cdp.10449","article-title":"The potential of the C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in colorectal cancer.","volume":"5","author":"Furukawa","year":"2025","journal-title":"Cancer Diagn Progn."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00134-024-07458-9","article-title":"Nutrition in the intensive care unit: From the acute phase to beyond.","volume":"50","author":"de Man","year":"2024","journal-title":"Intensive Care Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e988","DOI":"10.1097\/SLA.0000000000003708","article-title":"Early achievement of enteral nutrition protein goals by intensive care unit day 4 is associated with fewer complications in critically injured adults.","volume":"274","author":"Hartwell","year":"2021","journal-title":"Ann Surg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"230003","DOI":"10.1183\/16000617.0003-2023","article-title":"The role of diet and nutrition in the management of COPD.","volume":"32","author":"Beijers","year":"2023","journal-title":"Eur Respir Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"19366","DOI":"10.1021\/acs.jafc.4c03544","article-title":"Proanthocyanidins and \u03b2-glucan synergistically regulate intestinal inflammation in dextran sulfate sodium-induced colitis mice.","volume":"72","author":"Xia","year":"2024","journal-title":"J Agric Food Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/ATVBAHA.124.319870","article-title":"Reevaluating anti-inflammatory therapy: targeting senescence to balance anti-cancer efficacy and vascular disease.","volume":"45","author":"Casso-Chapa","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1016\/j.clnu.2021.02.019","article-title":"Region-specific COVID-19 risk scores and nutritional status of a high-risk population based on individual vulnerability assessment in the national survey data.","volume":"41","author":"Baik","year":"2022","journal-title":"Clin Nutr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1161\/CIRCRESAHA.122.321749","article-title":"Innate immunity system in patients with cardiovascular and kidney disease.","volume":"132","author":"Zoccali","year":"2023","journal-title":"Circ Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1161\/ATVBAHA.120.315310","article-title":"Endothelial TFEB (transcription factor EB) improves glucose tolerance via upregulation of IRS (insulin receptor substrate) 1 and IRS2.","volume":"41","author":"Sun","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American heart association\u2019s PREVENT equations.","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1811091\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:27:17Z","timestamp":1782480437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1811091\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":54,"alternative-id":["10.3389\/fmed.2026.1811091"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1811091","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"1811091"}}